Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine as add-on to SSRIs in OCD
NCT04904952Unknown
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Mar 2020
- Primary completion
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of acetylcysteine in obsessive compulsive disorder (OCD), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Yale-Brown Obsessive Compulsive Scale at 10 weeks. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
obsessive compulsive disorder (OCD)
Beyond the preview
Go deeper on NCT04904952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04904952.